乳化促进的KLF4多镇压在视网膜母细胞瘤中引起糖解:基因组修饰之间的正反回路
Ludi Yang1, Sipeng Zuo1, Ruobing Jia2
1Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, State Key Laboratory of Eye Health, Shanghai, 200025, PR China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, PR China.
Cancer letters
|May 18, 2025
概括
基斯的乳酸和甲基化形成了一个积极的反循环,驱动视网膜母细胞瘤的进展. 抑制SUZ12通过破坏癌症中的表观遗传代谢重编程,显示出治疗潜力.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 代谢重编程 代谢重编程
背景情况:
- 在癌症中,基因组基因修饰恒常是至关重要的,但瘤发生过程中修饰的相互作用仍然不清楚.
- 瘤基因激活和瘤抑制基因沉默与被破坏的基因组修饰模式有关.
- 了解这些表观遗传变化是开发新型癌症疗法的关键.
研究的目的:
- 阐明基因素乳酸和甲基化在视网膜母细胞瘤发育中的作用.
- 确定关键的分子参与者和参与癌症进展的反机制.
- 评估针对特定表观遗传调节者的治疗潜力.
主要方法:
- 在视网母细胞瘤中研究了基因素乳酸和H3K27me3修饰水平.
- 在体外和体外模型中利用了SUZ12抑制.
- 进行了多项omics分析,以确定下游效应因素.
- 检查了克鲁佩尔样因子4 (KLF4),糖解和基因素乳酸化之间的关系.
主要成果:
- 在视网膜母细胞瘤中通过SUZ12上调驱动的,鉴定了基因素乳酸和H3K27me3甲基化之间的积极反循环.
- 针对性抑制SUZ12显示出显著的治疗效果.
- 发现KLF4是SUZ12的下游效应因子,其抑制与增加糖解和乳酸积累有关.
- 表明乳酸增强了基因组的乳酸化,创造了一个自我强化的瘤生长周期.
结论:
- 揭示了一种新的表观遗传代谢反机制,涉及视网膜母细胞瘤中的乳酸和甲基化.
- 突出了SUZ12-KLF4轴在瘤基因激活和瘤抑制基因失活中的关键作用.
- 提供了针对癌症表观遗传代谢重编程的治疗策略的新见解.
相关概念视频
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


